Position in INCR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$11,353
+$9,803 QoQ
Shares Held
2,064
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 16 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quent Capital, LLC holds $2,423,759 across 13 Drug Manufacturers - Specialty & Generic names. INCR ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,104 | $2,223,670 | |
| 2 | VTRS |
Viatris Inc
|
3,722 | $59,105 | |
| 3 | ALKS |
Alkermes plc.
|
678 | $35,527 | |
| 4 | ZTS |
Zoetis Inc.
|
441 | $31,690 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
130 | $21,910 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
491 | $17,022 | |
| 7 | INCR |
Intercure Ltd.
This page
|
2,064 | $11,353 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
299 | $7,358 |
All Filings in INCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,353 | 10,321 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,550 | 10,321 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,878 | 10,321 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,385 | 10,321 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,034 | 10,321 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $2,889 | 10,321 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $3,282 | 10,321 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,149 | 10,321 | Shares | Sole | 2024-10-04 | |
| No filing history on record for this holder in this stock. | ||||||